Author:
Gomes Charles,Fisch Andressa,Marchioro Silvana,Tavares Lucas,Oliveira Natasha,Peiter Ana,Jorge Sérgio,Dellagostin Odir
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference5 articles.
1. Reynolds SC, St Aubin LB, Sabbadini LG, Kula J, Vogelaar J, Runnels P, Peters AR: Reduced lung lesions in pigs challenged 25 weeks after the administration of a single dose of Mycoplasma hyopneumoniae vaccine at approximately 1 week of age. The Veterinary Journal. 2009, 181: 312-320. 10.1016/j.tvjl.2008.03.012.
2. Shimoji Y, Oishi E, Muneta Y, Nosaka H, Mori Y: Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. Vaccine. 2003, 21: 532-537.
3. Chen YL, Wang SN, Yang WJ, Chen YJ, Lin HH, Shiuan D: Expression and immunogenicity of Mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccination. Infection and Immunity. 2003, 71: 1155-1160. 10.1128/IAI.71.3.1155-1160.2003.
4. Fagan PK, Djordjevic SP, Eamens GJ, Chin J, Walker MJ: Molecular characterization of a ribonucleotide reductase (nrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia. Infection and Immunity. 1996, 64: 1060-1064.
5. Tavares LA, Gomes CK, Fisch A, Marchioro S, Jorge S, Oliveira NR, Peiter AC, Conceição FR, Dellagostin OA: Design of synthetic gene for expression of a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens. Proceedings of the 59º Congresso Brasileiro de Genética: 16-19. 2013, September ; Águas de Lindóia